J2150 HCPCS Level II code: Injection, mannitol, 25% in 50 ml
CMS terminated J2150: its last date of service was Sep 30, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J2150Injection, mannitol, 25% in 50 ml
Short description: Mannitol injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J2150 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
- Terminated after
- Sep 30, 2025
Where J2150 sits
- 1J codesDrugs administered other than orally
- 2Terminated J2150Injection, mannitol, 25% in 50 ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J2150 still valid?
No. CMS terminated J2150; its last date of service was Sep 30, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J2150?
CMS lists J2150’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2150
All J codesJ2004Injection, lidocaine hcl with epinephrine, 1 mgJ2010Injection, lincomycin hcl, up to 300 mgJ2020Injection, linezolid, 200 mgJ2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mgJ2060Injection, lorazepam, 2 mgJ2062Loxapine for inhalation, 1 mgJ2151Injection, mannitol, 250 mgJ2170Injection, mecasermin, 1 mgJ2175Injection, meperidine hydrochloride, per 100 mgJ2180Injection, meperidine and promethazine hcl, up to 50 mgJ2182Injection, mepolizumab, 1 mgJ2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg